Register to participate

Advisory Committee

The Advisory Committee provides oversight of the project on behalf of the research team and helps guide it towards success. The specific roles of the Advisory Committee include: reviewing the activity, timelines, milestones, and deliverables, and commenting and advising on actions needed to ensure each workstream is meeting its responsibilities. Throughout the development of the project, the Advisory Committee will review iterations of the mobile application from the Minimal Viable Product through to the final prototype to be tested. The committee will provide advice on international perspectives and issues such as regulatory approvals needed to approve the mobile application beyond Australian context. They will also provide high level advice on how the device may be implemented in both private and public health sectors. Once the mobile application has been moved to feasibility testing in 2024-2025, the committee will also advise on actions needed to meet recruitment rates and regular reports of the various components of the project, and review adverse events and serious adverse events.

Name of MemberRole in ACInstitution
Prof Michael FineCo-ChairMacquarie University
Dr Sanka AmadoruCo-ChairAustin Health
Prof Felicity BakerPrincipal InvestigatorUniversity of Melbourne
Prof Nicola LautenschlagerChief InvestigatorUniversity of Melbourne
Prof Irene BlackberryIndependent InvestigatorLa Trobe University
Prof Claudia CooperIndependent InvestigatorQueen Mary University London
Dr Francine MossIndependent InvestigatorSt Vincent’s Melbourne
Robyn AttoeIndustry PartnerBupa
Valda GrovesIndustry PartnerVictorian Department of Health
Dr Tom MorrisIndustry PartnerThe Dementia Centre, HammondCare
Sarah YeatesIndustry PartnerCaladenia Dementia Care
Judy LowthianIndustry PartnerBolton Clarke Research Institute
Barry BaulchConsumer Representative
Asami KoikeAC CoordinatorUniversity of Melbourne